CHUGAI PHARMACEUTICAL CO., LTD.JP:4519Income statement

Market cap
¥17.29T
P/E ratio
2011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/122025/12
Revenue373,516391,220426,003461,109498,839491,780534,199579,787686,184786,946999,7591,259,9461,111,3671,170,6111,257,941
Revenue growth (%)-
Cost of revenue---214,484240,390244,836255,245264,430266,071273,465338,147476,251413,306339,409363,690
Gross profit---237,291249,370242,066270,807307,310420,113513,481661,612783,695698,061831,201894,251
Gross margin (%)---
Operating margin (%)---
Operating expenses ---165,381176,520173,018184,224197,744211,205222,217247,979260,242112,580110,098116,461
Operating income ---71,91072,85069,04886,583109,566210,597301,230421,897533,309439,174542,002598,833
Income before tax 63,58575,40677,76476,16487,27674,44897,031121,449207,893298,188419,385531,166443,821543,034597,807
Pretax margin (%)1719.318.316.517.515.118.220.930.337.941.942.239.946.447.5
Provision for income taxes---24,35823,23519,95321,06226,05850,33383,455116,390156,737118,349155,717163,794
Effective tax rate (%)---
Net income 35,23448,20550,89550,98061,12553,59272,71392,488157,560214,733302,995374,429325,472387,317434,012
Net income margin (%)
Earnings per share64.7588.5893.4793.5311298.12133.04169.08287.84130.66184.29227.64197.83235.39263.73
Diluted EPS64.7388.5492.8493.52102.7993.07127.37157.92287.43130.53184.17227.57197.8235.36263.72
Dividend payout ratio (%)---------
Dividend per share--------140-76788098272